News & Events
BD Biosciences Launches BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit
|
First in a series of ready-to-use kits offers a “total solution” approach for stem cell sorting and analysis
Contact: Jeff Ezell BD Public Relations (201) 847-5533 Email: jeff_ezell@bd.com San Jose, CA (December 15, 2008) -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the launch of the BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit – a comprehensive research system for the reliable characterization and cell sorting of human pluripotent stem cells using flow cytometry. This marks the first in a series of flow cytometry-based kits that BD Biosciences plans to release in the coming year. “As leading-edge biomedical research becomes increasingly complex, BD Biosciences is taking a total solutions approach to addressing scientists’ needs by developing powerful, integrated research tools to help reduce experiment complexity and improve dependability,” said William Rhodes, President, Cell Analysis, BD Biosciences. “The new BD Human Pluripotent Stem Cell Sorting and Analysis Kit will allow today’s researchers to deliver results with greater speed, precision and consistency.” This ready-to-use kit for the characterization and sorting of pluripotent stem cells includes pre-titrated fluorochrome conjugated antibodies, experiment set-up beads, validated protocols and software analysis templates. Designed as an integrated out-of-the-box application, the kit is optimized for use on existing BD flow cytometry instruments – the most widely used and well recognizedin cell analysis research. The integrated approach speeds adoption for less experienced flow cytometry users. It also minimizes assay-to-assay variability to help produce more dependable, comparable results faster.Its open design also allows for the easy addition of supplementary antibodies to adapt the kit to meet specific research objectives.
The BD Human Pluripotent Stem Cell Sorting and Analysis Kit enables the analysis and sorting of pluripotent stem cells.Its key features include:
“Flow cytometry is a powerful platform that can be an important tool in stem cell research, helping researchers rapidly separate rare stem cells from millions of other cells present in a tissue,” said Robert Balderas, Vice President, Biological Sciences, BD Biosciences. “BD Biosciences is a world leader and pioneer in the field of flow cytometry. Combining this experience with our knowledge and expertise in stem cell research, we are continually developing state-of-the-art, rigorously tested tools that are optimized to work together to help solve complex research problems.” BD Biosciences offers one of the most comprehensive portfolios of tools for stem cell researchers, spanning stem cell isolation, culture and analysis. For more information about the BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit, as well as other tools, please visit: http://www.bdbiosciences.com/stemcellsource About BD BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com.
# # #
|